Why is the FDA approving an AI product that predicts cognitive decline?
The US government has given approval to a San Francisco-based company, Darmiyan, for their AI-based memory loss prediction software. The FDA granted De Novo approval to the product, known as BrainSee. This software platform uses brain imaging analytics to provide accurate predictions.